BRIEF published on 06/10/2024 at 11:25, 5 months 11 days ago Semperit: Executive Board Chairman Karl Haider Will Not Extend His Contract Executive Board Supervisory Board Contract Semperit Karl Haider
BRIEF published on 06/10/2024 at 11:23, 5 months 11 days ago Semperit AG Holding: Executive Board Chairman Karl Haider Will Not Extend His Contract Executive Board Contract Semperit AG Holding Karl Haider
PRESS RELEASE published on 06/10/2024 at 11:20, 5 months 11 days ago Semperit: Executive Board Chairman Karl Haider will not extend his contract Semperit AG Holding's Executive Board Chairman Karl Haider will not extend his contract, citing personal reasons. Succession planning underway Succession Planning Semperit AG Holding Karl Haider Executive Board Chairman Semperit Group
PRESS RELEASE published on 06/10/2024 at 11:18, 5 months 11 days ago EQS-Adhoc: Semperit AG Holding: Executive Board Chairman Karl Haider will not extend his contract Semperit AG Holding's Executive Board Chairman Karl Haider announces he will not extend his contract, focusing on non-executive tasks. Search for successor to begin Contract Extension Semperit AG Holding Karl Haider Executive Board Chairman Successor Search
BRIEF published on 05/15/2024 at 07:35, 6 months 6 days ago Semperit Reports Stable Revenue and Increased EBITDA in Q1 2024 EBITDA Improvement Semperit AG Holding Q1 2024 Financial Results Revenue Stability Cost Reduction Strategies
PRESS RELEASE published on 05/15/2024 at 07:30, 6 months 6 days ago Semperit with stable revenue and 9% EBITDA increase in Q1 2024 Semperit reports stable revenue and 9% EBITDA increase in Q1 2024. Cost reductions ongoing. EBITDA guidance of around EUR 80 million for the year confirmed Financial Results EBITDA Revenue Cost Reductions Semperit
BRIEF published on 03/19/2024 at 07:39, 8 months 2 days ago Semperit AG Holding Reports Financial Results for 2023, Eyes Growth Despite Challenges Dividend Proposal Cost-cutting Measures Financial Results 2023 Semperit AG Holding Growth And Investment
PRESS RELEASE published on 03/19/2024 at 07:34, 8 months 2 days ago Semperit strengthened for further growth after transformation year – earnings 2023 still burdened by sold medical business Semperit AG Holding reports solid performance in 2023 despite challenges, focusing on cost reductions and strategic investments to drive future growth 2023 Earnings Strategic Investments Semperit AG Holding Cost Reductions Industrial Sector
BRIEF published on 03/05/2024 at 15:18, 8 months 15 days ago Semperit AG Holding Announces Dividend Proposal for 2023 Annual General Meeting Shareholder Value Dividend Financial Year 2023 Semperit AG Holding
PRESS RELEASE published on 03/05/2024 at 15:13, 8 months 15 days ago EQS-Adhoc: Semperit AG Holding: Semperit Executive Board proposes dividend of EUR 0.5 per share for 2023 Semperit AG Holding Executive Board proposes EUR 0.5 per share dividend for 2023. Annual General Meeting on 23 April 2024 Annual General Meeting 2023 Dividend Semperit AG Holding EUR 0.5
Published on 11/21/2024 at 13:30, 10 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:00, 40 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 40 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 40 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 13:00, 40 minutes ago Nextech3D.ai Spin-Out Rebrands as FOTOgpt.ai to Usher in a New Era of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 5 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 25 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 42 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 20 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 19 hours 55 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 19 hours 55 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 5 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
